Cerebras' blockbuster IPO turned its two co-founders into billionaires, based on their holdings in the chipmaker. A decade after starting Cerebras, CEO Andrew Feldman and hardware technology chief ...

Investors can’t seem to get enough of artificial intelligence infrastructure stocks, and that is pointing to massive demand for semiconductor chip designer Cerebras’ upcoming IPO. Cerebras CBRS, which ...

Inspire Brands, the owner of fast-food chains Dunkin’, Arby’s and Jimmy John’s, said Friday it had confidentially filed for a US initial public offering, as the consumer IPO market picks up steam ...

One of the commonly stated reasons why companies stay private is the costs (and legal risks) of being public. One of those costs is preparing quarterly SEC reports. But there are also costs of ...

Odyssey Therapeutics has become the latest biotech to voyage to the public markets via an upsized $304 million IPO this morning. The autoimmune- and inflammatory-disease-focused company first ...

I last wrote on SpaceX (SPACE) on Mar. 16, 2026. The article rated the stock as a buy after a comparison of its business model against the established United Launch Alliance (ULA). Since then, there ...

SpaceX’s plan to go public will reportedly give CEO Elon Musk “virtually unchecked executive authority” and limit the rights of shareholders to sue the company. The plan, reported by Reuters today, ...

Update, April 29 at 2:30 p.m.: Pershing Square opened down 16% in its IPO on Wednesday. PSUS shares were priced at $50 each, and opened around $42 per share. Bill Ackman has made a lot of noise in ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. When ...

A SpaceX IPO is expected this summer, and could be the largest IPO ever. But a report suggests that it will only be available through certain brokers. Many, or all, of the products featured on this ...

In another sign that the biotech IPO market is heating back up, Odyssey Therapeutics has made a fresh announcement of its intention to go public. The autoimmune- and inflammatory-disease-focused ...

The market for initial public offerings has been reignited with a bang, as the shares of two companies valued at more than $10 billion started trading on Thursday.